![Atrial Fib + "Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making. . ." - Tom Wade MD Atrial Fib + "Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making. . ." - Tom Wade MD](https://www.tomwademd.net/wp-content/uploads/2016/03/1.jpg)
Atrial Fib + "Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making. . ." - Tom Wade MD
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/f0c76a4b-279a-46cf-abea-39dfbbb036a3/e003476fig02.jpeg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ](https://www.bmj.com/content/bmj/342/bmj.d124/F3.large.jpg)
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study | The BMJ
Complications Associated With Catheter Ablation in Patients With Atrial Fibrillation: A Report From the JROADâ•'DPC Study
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/781dc0bb-505a-413e-b176-9b82fe0ae640/e003476fig04.jpeg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk](https://www.ahajournals.org/cms/asset/03a66d83-4788-498b-879e-2a74f1766f21/e003476fig01.jpeg)
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk
![Galen eCalcs - Calculator: CHA2DS2-VASc for Risk of Stroke - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki Galen eCalcs - Calculator: CHA2DS2-VASc for Risk of Stroke - Galen Healthcare Solutions - Allscripts TouchWorks EHR Wiki](https://wiki.galenhealthcare.com/images/2/2e/CHA2DS2_2019.png)